Rainbow Children's Medicare Ltd Share Price

Overview

Rainbow Children's Medicare Ltd share price is currently ₹1,412.91, down by - ₹12.70 (0.89%) from its previous closing price of ₹1,425.61. The share price has declined -3.3% over the past month and declined -8.17% over the past year. The stock's 52-week low and high are ₹1,069.98 and ₹1,597.81, respectively. Rainbow Children's Medicare Ltd has a market capitalisation of ₹ 14,530.00 Cr. The share price was last updated on 26 Aug 2026, 03:29 PM IST.

Rainbow Children's Medicare Ltd
Rainbow Children's Medicare Ltd
RAINBOW
 0.00
- 12.70
0.89%
Healthcare
 0.00(%)1D

Updated: 26 Aug 2026, 03:29:59 pm IST

Market Data

Open Price

 1,413.76

Prev. Close

 1,425.61
 1,382.42

Day Low

 1,440.57

Day High

 1,069.98

52 Week Low

 1,597.81

52 Week High

HealthcareHospital & Healthcare Services
CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

50.28

Sector PE

42.03

PB Ratio

8.73

Sector PB

5.83

EPS

28.10

Dividend Yield

0.30

Today's Volume

118.640 K

5 Day Avg. Volume

85.866 K

PEG Ratio

3.51

Market Cap.

₹ 14,530.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 35% at ₹3.5/Share
21-Jul-202621-Jul-2026
DividendsFinal Dividend of 30% at ₹3/Share
27-Jun-202528-Jun-2025

Mutual Fund Ownership

Mutual Fund Holder
Jun 26
Shares held
Jul 26
Shares held
ICICI Prudential Large & Mid Cap Fund - Growth24.46 Lac
24.46 Lac
no change
DSP Small Cap Fund - Regular Plan - Growth15.37 Lac
15.37 Lac
no change
ICICI Prudential Multi-Asset Fund - Growth13.50 Lac
13.50 Lac
no change
Motilal Oswal Small Cap Fund - Regular Plan - Growth12.38 Lac
13.50 Lac
(9.03%)
Axis Small Cap Fund - Regular Plan - Growth10.63 Lac
10.63 Lac
no change

About Rainbow Children's Medicare Ltd 👋

Rainbow Children's Medicare Limited is an India-based company, which is engaged in the business of rendering medical and healthcare services. The Company is a multi-specialty pediatric and obstetrics and gynecology hospital operating across approximately 20 hospitals and five outpatient clinics, spread across seven Indian cities, with a capacity of 2,035 beds. It offers pediatric services under Rainbow Children's Hospital, which include newborn and pediatric intensive care, pediatric multi-specialty services and pediatric quaternary care (including multi-organ transplants). Its women care services under Birthright by Rainbow that offers perinatal care services, which include normal and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility care, along with gynecology services. It also operates pediatric Diplomate of National Board (DNB) training programs in private healthcare, offering post-graduate residential DNB and fellowship programs.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Pavan Rawat

Pavan Rawat

26 Aug • 2:33 PM · SEBI-Registered Analyst

RAINBOW CHILDREN SHARES FALL ON CFO RESIGNATION

RAINBOW
Shares of Advait Energy Transitions gained 4% after the company received a turnkey contract worth ₹134.63 crore from Madhya Pradesh Power Transmission Co. Ltd. The order involves the design, manufacturing and supply of an Emergency Restoration System suitable for 400kV, 220kV and 132kV voltage-class extra-high-voltage transmission lines, along with all associated accessories. Sai Parenterals shares rose nearly 3% after its Australian subsidiary, Noumed Pharmaceuticals, renewed its OTC Medicines Supply Agreement with one of Australia’s leading multi-billion-dollar pharmacy chains. The renewed agreement includes an expanded product portfolio, a longer tenure and a higher contract value. The deal is estimated at AUD 30 million, or approximately ₹204 crore, over a three-year period and is effective immediately. Rainbow Children’s shares declined nearly 2% after the company announced that Vikas Maheshwari had resigned as Chief Financial Officer (CFO) and Key Managerial Personnel. His resignation will take effect from August 31, 2026, and is attributed to personal reasons. At the sectoral level, the PSU Bank index advanced 1%, while selling pressure was seen in consumer durables, IT and infrastructure stocks. The broader market remained positive, with both the Nifty Midcap and Nifty Smallcap indices gaining around 0.3% each.

See More
DEEPAK PAL

DEEPAK PAL

28 Jul • 1:28 PM · SEBI-Registered Analyst

IPO UPDATE----> Before You Apply for the Manipal Health IPO, Read This.

One of India's largest healthcare providers, Manipal Health Enterprises, is set to hit the primary market with one of the biggest IPOs of 2026. The company isn't raising capital just to list on the stock exchange—it is preparing for its next phase of expansion in India's rapidly growing healthcare sector. ##IPO Snapshot • IPO Size: ₹9,275 crore • Price Band: ₹560–₹590 per share • IPO Opens: 29 July 2026 • IPO Closes: 31 July 2026 • The issue comprises a fresh issue and an Offer for Sale (OFS). ***** Is This IPO Important? Manipal Health is among India's largest hospital networks, operating: 49 hospitals 13,000+ operational beds Presence across multiple Indian cities with a strong focus on tertiary and quaternary healthcare ------>Where Will the IPO Money Be Used? The company plans to: • Significantly reduce debt • Fund future expansion • Add 2,400–3,000 new beds over the next few years ##Why Could Healthcare Remain a Long-Term Theme? Several structural trends are supporting the sector: • Rising health insurance penetration • Increasing lifestyle diseases • Higher healthcare spending • Growing medical tourism ##Focus Stocks • Manipal Health Enterprises (Upcoming IPO) •

APOLLOHOSP
FORTIS
NH
MAXHEALTH
RAINBOW
----->Bottom Line Healthcare isn't just becoming a necessity—it's becoming one of India's biggest long-term growth industries. With an expanding hospital network, aggressive capacity addition, and a strategy to strengthen its balance sheet, Manipal Health is entering the public markets at a time when demand for quality healthcare continues to grow.

See More
Lovelesh Sharma

Lovelesh Sharma

13 Jul • 2:17 PM · SEBI-Registered Analyst

RAINBOW
- Momentum

I'm seeing Rainbow maintain a strong uptrend, supported by a fresh positive 20/50 moving average crossover and higher highs, higher lows. The crossover reinforces the bullish structure, while price continues to show positive momentum with buyers firmly in control. As long as the stock holds above the moving averages, I remain constructive and would expect strength to persist on dips.

RAINBOW

See More
Chahat Aggrawal

Chahat Aggrawal

24 May • 4:46 PM · SEBI-Registered Analyst

Rainbow Children’s Medicare FY26 PAT Rises 15%, Dividend Declared

🏥

RAINBOW
reported a 15.3% YoY rise in consolidated net profit to ₹2,815.44 million for FY26, while the board recommended a final dividend of ₹3.50 per share for shareholders.

See More
Tejaswi

Tejaswi

9 Apr • 5:40 AM · SEBI-Registered Analyst

Rainbow Beds: Profit Pivot Ahead?

RAINBOW
Rainbow Children's Medicare, India's top pediatric and perinatal hospital chain, runs about 2,300 beds across 22 hospitals and 5 clinics in 9 cities. Right now, only 47% of these beds are occupied, down from over 53% last year, due to recent additions like 80 beds in Rajahmundry and plans for 900 more by FY29, including 450 in Delhi-NCR. Shareholder Benefits from Expansion This low occupancy hurts short-term profits as fixed costs spread over fewer patients, causing EBITDA margins to dip slightly to 33% in Q3 FY26 despite 9% YoY EBITDA growth to Rs 1.5 billion. Revenue rose 12% YoY to Rs 4.5 billion, boosted by 9% higher ARPOB at Rs 58,400 per day from better case mix and shorter stays. Yet, it's highly valuable for long-term shareholders. Analysts see a profit inflection as new beds ramp up, projecting occupancy to 52-54% by FY26-28, driving 17-18% revenue CAGR and 19% EBITDA CAGR from FY26-28. The asset-light hub-spoke model ensures quick break-evens, high ROCE over 30%, and strong cash flows without debt, sustaining top margins. Risks and Upside Balance Expansion outpaces demand temporarily, pressuring stocks sector-wide through 2026, but Rainbow's specialty focus (70% pediatrics) gives pricing power and less competition. Healthy balance sheet supports Rs 900 crore capex internally. Overall, patient shareholders benefit as capacity unlocks massive growth in underserved child/mother care post-Covid, turning low occupancy into leveraged profits and superior returns.

See More
THREETREND RESEARCH

THREETREND RESEARCH

22 Feb • 11:06 AM · SEBI-Registered Analyst

Best Pharma & Healthcare Stocks in India! 💊 With strong domestic demand, export growth, and rising healthcare spending, this sector remains structurally strong 📈 🔎 Top Pharma & Healthcare Players: * Dr. Lal PathLabs * Lupin * Kovai Medical * Apollo Hospitals * Dr. Reddy’s Laboratories * Cipla * Thyrocare Technologies * Rainbow Children’s Medicare * Sun Pharma * Divi’s Laboratories * Global Health * QMS Medical * Metropolis Healthcare * Laurus Labs * Vaidya Ayurvedic Labs

LUPIN

See More

News & Events

Frequently Asked Questions

What is the share price of Rainbow Children's Medicare Ltd?

What is the market cap of Rainbow Children's Medicare Ltd?

Should I buy Rainbow Children's Medicare Ltd stock now?

What is the 52 week high and low of Rainbow Children's Medicare Ltd?

Is the Rainbow Children's Medicare Ltd stock good to buy?

Is Rainbow Children's Medicare Ltd a good buy for the long term?

Is Rainbow Children's Medicare Ltd overvalued or undervalued?

What is the PE and PB ratio of Rainbow Children's Medicare Ltd?

Start Now